CDC25A and neoplasm: However, CPX, at low concentrations (≤5 μM), drastically reduces the cellular protein level of Cdc25A, which results in increased inhibitory phosphorylation of G1-CDKs, leading to the accumulation of cells in G1 phase of the cell cycle in tumor cells [32].